Loading organizations...
Key people at Cain Brothers.
Cain Brothers is a New York City-based healthcare-focused investment banking firm that provides mergers and acquisitions advisory, debt and equity capital markets, and strategic services to healthcare organizations. Operating as a dedicated division of KeyBanc Capital Markets since its acquisition in 2017, the financial institution has successfully executed more than 200 M&A transactions since 2019. During this specific timeframe, the organization has advised on over $45 billion in total M&A transaction value across the broader healthcare economy. Under the leadership of executives including Rob Fraiman, the firm serves tax-exempt entities, private equity investors, and corporate clients across life sciences, medical technology, payers, and healthcare providers, recently advising on transactions involving entities like SuperCare Health. The specialized investment banking business was originally founded in 1982 by co-founders Jim Cain and Dan Cain.
Cain Brothers is a specialized investment bank focused exclusively on the healthcare sector, providing mergers and acquisitions (M&A) advisory, capital raising, debt financing, and strategic advisory services to healthcare providers, payers, product companies, and related services.[1][2][3][4][5] Now operating as a division of KeyBanc Capital Markets following its 2017 acquisition, the firm emphasizes deep industry expertise to deliver tailored financial solutions, with a track record including over $42 billion in M&A transaction value and 180+ deals since 2020, 80% of which closed at or above pitch range.[5] Its mission centers on addressing the unique needs of healthcare organizations through comprehensive services like equity/debt markets, fairness opinions, and valuations, primarily serving not-for-profit and for-profit entities in providers, life sciences, IT, and managed care.[1][3][5]
Founded in 1982 in New York, New York, Cain Brothers was established by professionals who recognized that healthcare organizations require specialized financial advice attuned to the industry's delivery system dynamics.[1][3] The firm started as an employee-owned investment bank and strategic advisory outfit dedicated solely to healthcare, growing into one of Wall Street's largest dedicated teams with offices nationwide.[3] A pivotal moment came in August 2017 when it was acquired by KeyBanc Capital Markets (Key), integrating its expertise as the "Cain Brothers" division while retaining its healthcare focus; this followed raising $4.26 million in prior funding.[1][5]
Cain Brothers rides the wave of healthcare's digital transformation and consolidation, where market forces like rising costs, regulatory shifts, technological advancements in IT/life sciences, and demand for specialized care drive M&A and capital needs.[2][5] Its timing aligns with post-pandemic sector evolution, facilitating expansions in behavioral health, biotech, and telehealth amid investor interest in scalable solutions.[1][5] By advising on high-value deals—such as Lakeview Health's acquisition by Bradford Health—the firm influences ecosystem consolidation, enabling providers to broaden geographic reach and deepen specialized services while channeling capital into innovation.[1]
Cain Brothers will likely expand its dominance in healthcare M&A and financing as AI-driven diagnostics, personalized medicine, and value-based care accelerate sector growth, leveraging KeyBanc's resources for larger deals in emerging areas like digital health and biotech.[5] Evolving regulations and economic pressures could heighten demand for its risk-optimized strategies, potentially growing its $42B+ M&A footprint amid ongoing provider consolidations. This positions it to shape healthcare's financial infrastructure, sustaining its role as a pivotal advisor from startups to enterprises.[2][5]
Key people at Cain Brothers.
